Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ampio Pharmaceuticals Inc announces positive results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion

Monday, 18 Aug 2014 08:00am EDT 

Ampio Pharmaceuticals Inc:Says 6 weeks results of the open label portion of the multiple injections of Ampion into the knees of patients (n=7) with osteoarthritis (OA).Results so far are encouraging. 

Company Quote

0.17 +5.21%
24 Dec 2014